Key Points
- Director Michael Beindorff sold 10,000 Lifevantage shares for $48,900, reducing his direct stake by 24.02% to 31,625 shares.
- Lifevantage’s latest quarter fell short of expectations: earnings were $0.05 per share versus a $0.06 estimate, and revenue was $37.12 million versus forecasts of $40.49 million.
- The company announced a quarterly dividend of $0.05 per share, equal to a 4.2% annualized yield; analysts’ consensus rating was Hold, with a $6.75 average price target.
Lifevantage Corporation (NASDAQ:LFVN - Get Free Report) Director Michael Beindorff sold 10,000 shares of the stock in a transaction dated Thursday, November 12th. The stock was sold at an average price of $4.89, for a total transaction of $48,900.00. Following the transaction, the director directly owned 31,625 shares in the company, valued at $154,646.25. This trade represents a 24.02% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Lifevantage Trading Down 4.0%
LFVN opened at $4.77 on Tuesday. Lifevantage Corporation has a 1-year low of $3.90 and a 1-year high of $11.71. The company has a market cap of $60.48 million, a price-to-earnings ratio of 11.72 and a beta of 0.71. The company's fifty day moving average price is $5.90 and its two-hundred day moving average price is $5.85.
Lifevantage (NASDAQ:LFVN - Get Free Report) last issued its quarterly earnings data on Monday, November 9th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.01). The company had revenue of $37.12 million during the quarter, compared to analysts' expectations of $40.49 million. Lifevantage had a return on equity of 16.35% and a net margin of 1.58%.
Lifevantage Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Tuesday, December 1st will be given a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 4.2%. The ex-dividend date of this dividend is Tuesday, December 1st. Lifevantage's dividend payout ratio (DPR) is currently 95.24%.
Hedge Funds Weigh In On Lifevantage
A number of hedge funds and other institutional investors have recently bought and sold shares of LFVN. Engineers Gate Manager LP increased its holdings in shares of Lifevantage by 109.7% in the 2nd quarter. Engineers Gate Manager LP now owns 27,009 shares of the company's stock worth $169,000 after buying an additional 14,131 shares during the last quarter. Bank of New York Mellon Corp bought a new stake in shares of Lifevantage during the 2nd quarter worth $78,000. Bank of America Corp DE lifted its holdings in shares of Lifevantage by 24.3% during the 1st quarter. Bank of America Corp DE now owns 23,445 shares of the company's stock worth $101,000 after acquiring an additional 4,586 shares during the last quarter. Finally, Hsbc Holdings PLC bought a new stake in shares of Lifevantage during the 1st quarter worth $51,000. Hedge funds and other institutional investors own 35.32% of the company's stock.
Wall Street Analyst Weigh In
A number of brokerages recently issued reports on LFVN. Freedom Broker dropped their price objective on Lifevantage from $9.00 to $8.00 and set a "buy" rating on the stock in a report on Friday. Zacks Research downgraded Lifevantage from a "hold" rating to a "strong sell" rating in a research report on Friday, October 16th. UBS Group set a $8.00 price objective on Lifevantage in a research note on Friday. Weiss Ratings cut Lifevantage from a "hold (c)" rating to a "hold (c-)" rating in a research report on Friday. Finally, Lake Street Capital upped their target price on Lifevantage from $5.00 to $6.00 and gave the stock a "hold" rating in a research note on Friday, August 28th. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Lifevantage currently has an average rating of "Hold" and a consensus target price of $6.75.
Check Out Our Latest Research Report on Lifevantage
About Lifevantage
(
Get Free Report)
LifeVantage Corporation is a health and wellness company that develops and sells dietary supplements, skincare products and other wellness offerings. Its product range includes Protandim supplements and the TrueScience skincare line, with products marketed around the company's focus on nutrigenomics—the study of how nutrition interacts with gene expression. Founded in 2003, LifeVantage primarily sells through independent consultants and online channels. The company serves customers in markets across North America, Europe and the Asia-Pacific region.
Further Reading

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].